Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Choline vs Saffron: Saffron has the stronger overall evidence (7.5 vs 6/10); they're alternatives for brain aging support — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Saffron wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mixed evidence
1 of 3 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
5 of 5 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Choline and Saffron have evidence — compare verdict strength side-by-side.
250-500mg daily (varies by form)
Morning or with meals, Alpha-GPC before cognitive tasks
Alpha-GPC or CDP-Choline (Citicoline)
28-30mg daily
Morning or split AM/PM
Affron® standardized extract
2-4 weeks
4-8 weeks
1-2 weeks
With high doses
4-8 weeks
4-8 weeks
2 menstrual cycles
Association of choline and betaine with the risk of cardiovascular disease and all-cause mortality: Meta-analysis
European journal of clinical investigation (2023) · Meta analysis · n=33009
Random-effects model results showed that highest versus lowest quantile of circulating choline concentrations were associated with the risk of CVD (RR = 1.29, 95% CI: 1.04-1.61) and all-cause mortality (RR = 1.62, 95% CI: 1.12-2.36).
Higher dietary choline intake is associated with increased risk of all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of cohort studies
Nutrition research (New York, N.Y.) (2024) · Meta analysis · n=482778
This study showed that each 100 mg/day increment in choline consumption was significantly associated with a 6% and 11% higher risk of all-cause and cardiovascular disease mortality respectively.
Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
Journal of Alzheimer's disease : JAD (2023) · Meta analysis
We found significant effects of α-GPC in combination with donepezil on cognition [4 RCTs, mean difference (MD):1.72, 95% confidence interval (CI): 0.20 to 3.25], functional outcomes [3 RCTs, MD:0.79, 95% CI: 0.34 to 1.23], and behavioral outcomes [4 RCTs; MD: -7.61, 95% CI: -10.31 to -4.91].
Comparative efficacy and tolerability of nutraceuticals for depressive disorder: A systematic review and network meta-analysis
Psychological medicine (2025) · Meta analysis · n=17437
Hundred and ninety-two trials involving 17,437 patients and 44 nutraceuticals were eligible for inclusion.
Systematic Review and Network Meta-Analysis of the Effects of Plant Extracts on Cognitive Function and Quality of Life in Stroke Patients
Phytotherapy research : PTR (2025) · Meta analysis · n=6599
48 eligible randomized controlled trials were included, covering 6599 stroke patients and evaluating nine different plant extract treatments, one of which was Crocus sativus (saffron).
New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms
Phytotherapy research : PTR (2024) · Systematic review
A random-effects or fixed-effects model was used to calculate the pooled effect sizes.
Both points are doses of a standardised saffron extract (affron) in adults with low mood. A 4-week RCT in 128 adults (PMID 28735826) gave 22 or 28 mg a day: mood improved at 28 mg (POMS total mood disturbance versus placebo, d = -1.10) with no effect at 22 mg. A 12-week RCT in 202 adults with subclinical depressive symptoms (PMID 40414301) confirmed a smaller benefit at 28 mg (DASS-21 depression, d = 0.39). Doses above 28 mg were not compared with lower ones in these trials, so no optimal dose or safety ceiling is plotted. The cited depression meta-analyses pool trials without comparing doses.
AI-estimated from published studies. Interpret as directional guidance.
Saffron has a higher evidence score (7.5/10 vs 6/10) and wins in 2 of 3 categories.
For brain aging support, Saffron has a higher relevance score (70 vs 65).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Weight loss is the real treatment; vitamin E/omega-3 have some evidence, milk thistle modest, TUDCA thin.
What’s safe while nursing, the truth about milk-supply herbs, and what to avoid (it passes into milk).
Commonly recommended vs ask-your-clinician vs avoid — a general, safety-first overview.
Saffron, EPA omega-3, SAMe have real adjunct evidence — but these aren’t a substitute for care, and some interact dangerously.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.